학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 618건 | 목록 1~20
Academic Journal
Frostegård E; CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, Strasbourg, France.; Bobrova T; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine-University Paris-Sud, Université Paris-Saclay, Villejuif, France.; Leinebø A; University of Paris City, CNRS, Inserm, NABI, Paris, France.; Leray T; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Medical Faculty, University of Oslo, Oslo, Norway.; Ghosh S; The Nanomedicine Group, Universidad de Cantabria-Instituto de Investigación Valdecilla-IDIVAL Avda Herrera Oria s/n, Santander, Spain.; García-Hevia L; The Nanomedicine Group, Universidad de Cantabria-Instituto de Investigación Valdecilla-IDIVAL Avda Herrera Oria s/n, Santander, Spain.; Puccinelli C; Institute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.; Riccio L; Institute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.; Sorani J; Swiss Federal Laboratories for Materials Science and Technology (Empa), Technology and Society Laboratory, St. Gallen, Switzerland.; Bonifazi D; Institute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.; Caumartin J; Exosiris, Le Vésinet, France.; Donnadieu E; INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine-University Paris-Sud, Université Paris-Saclay, Villejuif, France.; Gazeau F; University of Paris City, CNRS, Inserm, NABI, Paris, France.; Hischier R; Swiss Federal Laboratories for Materials Science and Technology (Empa), Technology and Society Laboratory, St. Gallen, Switzerland.; Inderberg EM; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Fanarraga ML; The Nanomedicine Group, Universidad de Cantabria-Instituto de Investigación Valdecilla-IDIVAL Avda Herrera Oria s/n, Santander, Spain.; Loustau M; Exosiris, Le Vésinet, France.; Nowack B; Swiss Federal Laboratories for Materials Science and Technology (Empa), Technology and Society Laboratory, St. Gallen, Switzerland.; Wälchli S; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Ménard-Moyon C; CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, Strasbourg, France.; University of Strasbourg Institute of Advanced Study (USIAS), Strasbourg, France.
Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
Academic Journal
Gjerde CH; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; Department of Obstetrics and Gynecology, Haukeland University Hospital, Haukelandsbakken 15, 5021, Bergen, Norway. Electronic address: christiane.gjerde@uib.no.; Kleinmanns K; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway. Electronic address: katrin.kleinmanns@uib.no.; Langer A; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway. Electronic address: ani-lan@web.de.; Ruiz de Garibay Ponce G; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway. Electronic address: gruizde@aesan.gob.es.; Rozmus E; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; Department of Physiology, University of Kentucky, 741 S. Limestone, BBSRB, B243, Lexington, KY, 40536, USA. Electronic address: ezekiel.rozmus@uky.edu.; Stangeland GN; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway. Electronic address: gina.stangeland@student.uib.no.; Leitch C; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway. Electronic address: calum.leitch@uib.no.; Elnour R; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; Gade Laboratory of Pathology, Department of Clinical Medicine, University of Bergen, Jonas Lies vei 91 B, 5021, Bergen, Norway. Electronic address: rammah.mustafa@uib.no.; Dongre HN; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; Gade Laboratory of Pathology, Department of Clinical Medicine, University of Bergen, Jonas Lies vei 91 B, 5021, Bergen, Norway. Electronic address: harsh.dongre@uib.no.; Berger C; Department for Functional Materials in Medicine and Dentistry, University Hospital Würzburg, Röntgenring 11, Würzburg, Germany. Electronic address: constantin.berger@uni-wuerzburg.de.; Gultekin O; Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Solnavägen 9, 17165, Solna, Stockholm, Sweden. Electronic address: okan.gultekin@ki.se.; Forcados C; Faculty of Medicine, University of Oslo, Sognsvannsveien 9, 0372, Oslo, Norway; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Ullernchausséen 64, 0379, Oslo, Norway. Electronic address: chforc@ous-hf.no.; Stensland M; Department of Immunology, University of Oslo and Oslo University Hospital, Sognsvannsveien 20, Rikshospitalet, 0372, Oslo, Norway. Electronic address: maria.stensland@medisin.uio.no.; Nyman TA; Department of Immunology, University of Oslo and Oslo University Hospital, Sognsvannsveien 20, Rikshospitalet, 0372, Oslo, Norway. Electronic address: tuula.nyman@medisin.uio.no.; Lehti K; Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Solnavägen 9, 17165, Solna, Stockholm, Sweden; Department of Biomedical Laboratory Science, Norwegian University of Science and Technology, Erling Skjalgssons Gate 1, 7030, Trondheim, Norway. Electronic address: kaisa.lehti@ntnu.no.; Davidson B; Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, Ullernchausséen 70, 0379, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway. Electronic address: bend@medisin.uio.no.; Wälchli S; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Ullernchausséen 64, 0379, Oslo, Norway. Electronic address: sebastw@ous-hf.no.; Gelebart P; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; Department of Hematology, Haukeland University Hospital, Jonas Lies vei 83, 5021, Bergen, Norway. Electronic address: pascal.gelebart@uib.no.; Costea DE; Centre for Cancer Biomarkers CCBIO and Gade Laboratory of Pathology, Department of Clinical Medicine, University of Bergen, Jonas Lies vei 91 B, 5021, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Jonas Lies vei 91 B, 5021, Bergen, Norway. Electronic address: daniela.costea@uib.no.; Kotopoulis S; National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Jonas Lies vei 83, 5021, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Jonas Lies vei 91 B, 5021, Bergen, Norway. Electronic address: Spiros.Kotopoulis@uib.no.; Bjørge L; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; Department of Obstetrics and Gynecology, Haukeland University Hospital, Haukelandsbakken 15, 5021, Bergen, Norway. Electronic address: line.bjorge@uib.no.; McCormack E; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; K.G. Jebsen Center for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Jonas Lies vei 87, 5021, Bergen, Norway; Department of Hematology, Haukeland University Hospital, Jonas Lies vei 83, 5021, Bergen, Norway. Electronic address: emmet.mc.cormack@uib.no.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Report
Hanuš, J.Ďurech, J.Brož, M.Marciniak, A.Warner, B. D.Pilcher, F.Stephens, R.Behrend, R.Carry, B.Čapek, D.Antonini, P.Audejean, M.Augustesen, K.Barbotin, E.Baudouin, P.Bayol, A.Bernasconi, L.Borczyk, W.Bosch, J. -G.Brochard, E.Brunetto, L.Casulli, S.Cazenave, A.Charbonnel, S.Christophe, B.Colas, F.Coloma, J.Conjat, M.Cooney, W.Correira, H.Cotrez, V.Coupier, A.Crippa, R.Cristofanelli, M.Dalmas, Ch.Danavaro, C.Demeautis, C.Droege, T.Durkee, R.Esseiva, N.Esteban, M.Fagas, M.Farroni, G.Fauvaud, M.Fauvaud, S.Del Freo, F.Garcia, L.Geier, S.Godon, C.Grangeon, K.Hamanowa, H.Heck, N.Hellmich, S.Higgins, D.Hirsch, R.Husarik, M.Itkonen, T.Jade, O.Kamiński, K.Kankiewicz, P.Klotz, A.Koff, R. A.Kryszczyńska, A.Kwiatkowski, T.Laffont, A.Leroy, A.Lecacheux, J.Leonie, Y.Leyrat, C.Manzini, F.Martin, A.Masi, G.Matter, D.Michałowski, J.Michałowski, M. J.Michałowski, T.Michelet, J.Michelsen, R.Morelle, E.Mottola, S.Naves, R.Nomen, J.Oey, J.Ogloza, W.Oksanen, A.Oszkiewicz, D.Pääkkönen, P.Paiella, M.Pallares, H.Paulo, J.Pavic, M.Payet, B.Polińska, M.Polishook, D.Poncy, R.Revaz, Y.Rinner, C.Rocca, M.Roche, A.Romeuf, D.Roy, R.Saguin, H.Salom, P. A.Sanchez, S.Santacana, G.Santana-Ros, T.Sareyan, J. -P.Sobkowiak, K.Sposetti, S.Starkey, D.Stoss, R.Strajnic, J.Teng, J. -P.Tregon, B.Vagnozzi, A.Velichko, F. P.Waelchli, N.Wagrez, K.Wücher, H.
Academic Journal
Bobrowicz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Kusowska A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Krawczyk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Zhylko A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Forcados C; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Slusarczyk A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland.; Barankiewicz J; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Faculty of Medicine, Lazarski University, Warsaw, Poland.; Domagala J; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Kubacz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Šmída M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Dostalova L; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Marhelava K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Pepek M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Baranowska I; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Szumera-Cieckiewicz A; Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Biobank, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Inderberg EM; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Wälchli S; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Granica M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Graczyk-Jarzynka A; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Majchrzak M; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Poreba M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland.; Gehlert CL; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.; Peipp M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.; Firczuk M; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Prochorec-Sobieszek M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany.; Winiarska M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
Abrantes R; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.; Forcados C; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway; Faculty of Medicine, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway.; Warren DJ; Department of Medical Biochemistry, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.; Santos-Ferreira L; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.; Fleten KG; Department of Tumor Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Ullernchausséen 70, 0379 Oslo, Norway.; Senra E; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Costa AF; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.; Krpina K; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway; Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.; Henrique R; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal; Department of Pathology & Cancer Biology and Epigenetics Group - Research Center (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.; Liberg AM; Faculty of Medicine, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway.; Rawat P; Department of Immunology, University of Oslo and Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.; Gelebart P; Department of Clinical Science, Precision Oncology Research Group, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway; CCBIO - Centre for Cancer Biomarkers, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.; McCormack E; Department of Clinical Science, Precision Oncology Research Group, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway; CCBIO - Centre for Cancer Biomarkers, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway; Department of Hematology, Haukeland University Hospital, Jonas Lies vei 65, 5021 Bergen, Norway; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway.; Bjørge L; CCBIO - Centre for Cancer Biomarkers, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway; Department of Obstetrics and Gynecology, Haukeland University Hospital, Jonas Lies vei 65, 5021 Bergen, Norway.; Davidson B; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.; Greiff V; Department of Immunology, University of Oslo and Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.; Costea DE; CCBIO - Centre for Cancer Biomarkers, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway; Department of Clinical Medicine, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway; Gade Laboratory for Pathology, Haukeland University Hospital, Jonas Lies vei 65, 5021 Bergen, Norway.; Pinto F; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Flatmark K; Department of Tumor Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Ullernchausséen 70, 0379 Oslo, Norway; Department of Surgical Oncology, Norwegian Radium Hospital, Oslo University Hospital, Ullernchausséen 70, 0379 Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway.; Gomes C; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal.; Inderberg EM; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.; Reis CA; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal; FMUP - Faculdade de Medicina da Universidade do Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal. Electronic address: celsor@i3s.up.pt.; Wälchli S; Translational Research Unit, Department of Cellular Therapy, Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway. Electronic address: sebastw@ous-hf.no.
Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
Academic Journal
Rosselle L; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: lea.rosselle@rr-research.no.; Leray T; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Medical Faculty, University of Oslo, Oslo, Norway.; Joaquina S; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Medical Faculty, University of Oslo, Oslo, Norway.; Caulier B; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute for Cancer Research, Department of Molecular Cell Biology, Oslo University Hospital, Oslo, Norway; Center for Cancer Cell Reprogramming (CanCell), Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; McCormack E; Department of Clinical Science, Precision Oncology Research Group, University of Bergen, 5021 Bergen, Norway; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, Norway; Centre for Cancer Biomarkers (CCBIO), University of Bergen, Bergen, Norway.; Gelebart P; Department of Clinical Science, Precision Oncology Research Group, University of Bergen, 5021 Bergen, Norway; Centre for Cancer Biomarkers (CCBIO), University of Bergen, Bergen, Norway.; Wälchli S; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Inderberg EM; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: else.marit.inderberg@rr-research.no.
Publisher: Cell Press Country of Publication: United States NLM ID: 101769501 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-1667 (Electronic) Linking ISSN: 26661667 NLM ISO Abbreviation: STAR Protoc Subsets: MEDLINE
Academic Journal
Marhelava K; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Pepek M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Krawczyk M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Centre of Postgraduate Medical Education, Warsaw, Poland.; Forcados C; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Malinowska A; Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.; Swiderska B; Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.; Fernandez-Fuentes N; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Czerwik N; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Baranowska I; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Krzywdzinska A; Laboratory of Immunophenotyping, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Sedek L; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Slota L; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland.; Perkowski B; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland.; Villatoro A; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Leray T; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Lech-Maranda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Menendez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red-Oncología, Instituto de Salud Carlos III, Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Institut de Recerca Hospital Sant Joan de Déu-Pediatric Cancer Center Barcelona (SJD-PCCB), Barcelona, Spain.; Inderberg EM; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Wälchli S; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Winiarska M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland. mwiniarska@imdik.pan.pl.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland. mwiniarska@imdik.pan.pl.; Firczuk M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland. mfirczuk@imdik.pan.pl.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland. mfirczuk@imdik.pan.pl.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Krawczyk M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Centre of Postgraduate Medical Education, Warsaw, Poland.; Fernandez-Fuentes N; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Winiarski T; Warsaw University of Technology, Institute of Control and Computation Engineering, Warsaw, Poland.; Pepek M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Graczyk-Jarzynka A; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Davis J; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Bousquets-Muñoz P; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Puente XS; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Menendez P; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III (ISCII).; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Institut de Recerca Hospital Sant Joan de Déu-Pediatric Cancer Center Barcelona (SJD-PCCB), Barcelona, Spain.; Benard E; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Wälchli S; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Thomas-Tikhonenko A; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Winiarska M; Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Maggadóttir SM; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Kvalheim G; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Wernhoff P; Department of Medical Genetics, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.; Sæbøe-Larssen S; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Revheim ME; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.; Josefsen D; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Wälchli S; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.; Helland Å; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Inderberg EM; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Wälchli, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어